Nrc Health · NASDAQ:NRC

Nrc Health — Investor Presentation (July 2026)

26 slides from Nrc Health's investor presentation, July 2026

  1. Slide 1: NRC Health Investor Presentation Fall 2026

    NRC Health Investor Presentation Fall 2026

  2. Slide 2: Legal Disclaimer

    Legal Disclaimer Cautionary Language Concerning Forward-Looking Statements In this presentation, we may make statements related to our business that are “forward-looking statements” about the Company’s financial and operating results which include, but are not limited to, expected GAAP and non-GAAP

  3. Slide 3: Our Mission

    OUR MISSION Healthcare experience insights and improvement solutions To partner with health systems to understand every person they serve and turn that insight into actions that drive improved outcomes Rich data & Predictive insights for Trusted healthcare workflow software frontline & executive exp

  4. Slide 4: Strong Performance Metrics

    Strong Performance 99% $152M+11% y/y 27% $5B Metrics Recurring Annual Recurring Adj EBITDA TAM Revenue Contract Value Margin (LTM) (TRCV) Leading Presence in 45 75% 25M+ #1 Healthcare Years of Healthcare of Top-100 Health Patient Engagements Rank in Healthcare Experience Systems as Customers Annuall

  5. Slide 5: We are Improving the Challenged Healthcare Ecosystem

    We are Improving the Challenged Healthcare Ecosystem 96% of patient complaints relate to customer service (4% related to clinical care) Efficient Higher brand 75% Better experiences Improved care operations loyalty of frequent healthcare consumers are frustrated 49% Continuous understanding of Insig

  6. Slide 6: Q2 2026 Highlights

    Q2 2026 Highlights Double-digit TRCV growth and AI-based solution launch $152M TRCV, +11% y/y TRCV Increase • Strong leading indicator of revenue “Our second quarter was a success on many fronts, including double- • Strength in Experience and TGI sales digit TRCV growth over the prior year, strong g

  7. Slide 7: Compounding Investment Thesis

    Compounding Investment Thesis  Made for healthcare, focused on healthcare, trusted by healthcare  Decades of experience and vertical insights Vertical Market Presence  75% of the top-100 U.S. hospital systems and 64% of the top-400 as customers  End-to-end solution driving tangible customer ROI

  8. Slide 8: Experienced Leadership Team

    Experienced Leadership Team Significant healthcare industry experience combined with strong technology proficiency Trent Green Helen Hrdy Andy Monnich Chief Executive Officer Chief Operating Officer Chief Corporate Development Officer Joined NRC in 2025 26 years with NRC Rejoined NRC in 2024 | 9 yea

  9. Slide 9: Our History

    Our History Today: Leading Presence in Empowering Healthcare Revenue: $137M Today Partnering with the largest health systems, representing over 13,000 healthcare facilities, and listening to 25M+ consumer voices annually on our journey of Human Understanding 2024 1997-2025: Platform Expansion • Acqu

  10. Slide 10: Our Solutions – Experience

    Our Solutions – Experience Patient and Employee Feedback Survey management and care tracking solutions to evaluate and improve vital moments across the health journey Reputation Management Automated monitoring and management tools to enhance online reviews, ratings, and consumer engagement Driving B

  11. Slide 11: Our Solutions – Enablement

    Our Solutions – Enablement Workflow Automation Structured patient and employee rounding plans and service alerts for nurses, doctors, and administrators Interventions Proactive and personalized suggestions for patient conversations, outreach prioritizations, and care monitoring Improving Care Qualit

  12. Slide 12: Our Solutions – Strategic Insights

    Our Solutions – Strategic Insights Market Insights Largest healthcare market survey collecting the preferences and demographics of ~300k consumers annually Continuous and Deep Large, continuously updated 25+ year longitudinal dataset made up of consumer sentiment metrics related to healthcare delive

  13. Slide 13: Our Solutions – Governance

    Our Solutions – Governance Board Best Practices Tools empowering successful board structuring, communications, policies, performance measurement, recruitment, and planning Education Curated resources to train leaders and directors on healthcare sector regulation, risk management, onboarding, and cer

  14. Slide 14: Differentiators – Platform Breadth

    Differentiators – Platform Breadth End-to-End Solution for Improving Healthcare 1 Data Capture 4 Enable • Patient feedback • Automated workflow tools • Employee feedback • Leveraging tech to • Consumer feedback connect insights to action Enabling a continuous improvement cycle for health systems to

  15. Slide 15: Differentiators – Trust

    Differentiators – Trust The Brand That Healthcare Relies On Selected Customers #1 Ranked Experience Management Certified HITRUST data security “ WHY NRC HEALTH “NRC Health has been exceptional in meeting us where we were and taking us where we needed to be.” Trust & provider for trust 1 infrastructu

  16. Slide 16: Differentiators – Expertise

    Differentiators – Expertise Purpose-Built for the Healthcare Market Tenure & NRC Health research defined Patient-Centered Care and Proven thought leadership and research teams Adapt proven best practices from other industries to create Experience pushed the industry to focus on patient experience de

  17. Slide 17: Integrating AI to Save the Front-Line Time

    Integrating AI to Save the Front-Line Time +75% increase in comment capture rate AI Ambient Listening 60x increase in documentation detail Conversational Experience Innovating & Search Concierge Automating Healthcare data-focused AI Sentiment & NRC Health Frontline Theme Analysis AI Coach engines an

  18. Slide 18: Case Studies: How We Drive Results

    Case Studies: How We Drive Results Customer Weakening customer experience Slow response to online reviews Steep growth in one of the fastest- Desire to reduce patient Their scores leading to low customer loyalty of clinicians and facilities, growing regions in the U.S. readmittances to reduce the co

  19. Slide 19: $5 Billion Runway for Growth

    $5 Billion Runway for Growth Current revenue base $137M 70% of customers Cross-sell whitespace with existing products +$0.7B using 1 product 1 $0.8B New logo whitespace with existing products +$0.6B $1.4B Strategic Insights market expansion +$1.4B $2.8B Quality management software opportunity +$0.8B

  20. Slide 20: Compelling and Durable Financial Profile

    Compelling and Durable Financial Profile Leveraging Market Growing & Recurring Meaningful Operating Disciplined Capital Strong FCF Conversion Differentiators Revenue Leverage Deployment Adj Net Income Adj Operating Income $21M Adj EBITDA $33M $40M $0.93 per share Adj FCF 1 2025 24% Margin 29% Margin

  21. Slide 21: Highly Predictable Business Model

    Highly Predictable Business Model Recurring Revenue Contract Length TRCV & Revenue TRCV Next 12 mos Revenue Recurring 2019 98% 99% 2020 102% 2021 100% 3+ Yrs 1 Yr 45% 47% 2022 101% 2023 Non- 101% Recurring 2024 1% 2 Yrs 103% 8% 2025 Nearly all solutions structured as Growing number of multi-year Hig

  22. Slide 22: Return to Top Line Growth

    Return to Top Line Growth TRCV $147 $152 Long-Term Growth Catalysts $138 $137 Drivers of TRCV Inflection → New sales organization leadership +11% Go-to-market process → Investment in Sales team Penetration of optimization and Enablement solutions → Restructured selling processes execution → Product

  23. Slide 23: Strong Profitability and Cash Generation

    Strong Profitability and Cash Generation Adj EBITDA Margin 39% 39% 39% Attainable path to return to high-30s margin 33% 32% 29% 29% • Strong incremental margins on inflecting top line • Disciplined hiring • Process improvement • Vendor consolidation 2019 2020 2021 2022 2023 2024 2025 Adj FCF Convers

  24. Slide 24: Disciplined Capital Allocation to Drive Shareholder Value

    Disciplined Capital Allocation to Drive Shareholder Value $ in millions Maintain $80 Strong & Flexible Balance Sheet • Preserve sufficient liquidity to execute on $70 opportunities and strategies $60 R&D as % of Invest $50 Revenue 8% in Growth • High ROI initiatives to drive organic growth $40 CapEx

  25. Slide 25: Compounding Investment Thesis

    Compounding Investment Thesis  Made for healthcare, focused on healthcare, trusted by healthcare  Decades of experience and vertical insights Vertical Market Presence  75% of the top-100 U.S. hospital systems and 64% of the top-400 as customers  End-to-end solution driving tangible customer ROI

  26. Slide 26: Appendix: Non-GAAP Reconciliations

    Appendix: Non-GAAP Reconciliations Reconciliation of Operating Income to Adjusted Operating Income Reconciliation of Net Income to Adjusted Net Income ($ in thousands) Q226 Q225 2025 2024 2023 ($ in thousands) Q226 Q225 2025 2024 2023 Operating income ($3,239) $1,588 $22,590 $35,194 $40,045 Net inco

NRC Health — Investor Presentation (July 2026) on 6ix